Membership from 1 April 2022
- Professor Simon Hollingsworth (Chair), AstraZeneca
- Professor Sebastien Ourselin, King’s College London
- Professor Oliver Bandmann, The University of Sheffield
- Mrs Pamela Brown, Pam Brown Consulting Ltd
- Professor Helen Fletcher, London School of Hygiene & Tropical Medicine
- Professor Tim Harrison, Almac Discovery & Queen’s University Belfast
- Dr Ranil De Silva, National Heart and Lung Institute, Imperial College
- Professor Fiona Thistlethwaite, Faculty of Biology, Medicine & Health, The University of Manchester
- Professor Christopher Scott, Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast
- Dr Nicola Wallis, Astex Pharmaceuticals
- Professor Giovanni Montana, WMG (Warwick Manufacturing Group), University of Warwick
- Professor Enitan Carrol, Institute of Infection & Global Health, University of Liverpool
- Dr Hayley Whitaker, University College London
- Professor Fadi Issa, University of Oxford
- Professor Divya Maitreyi Chari, Keele University School of Medicine
- Dr Richard May, Sosei Heptares
- Professor Francis Drobniewski, Imperial College London
- Professor Payam Barnaghi, Imperial College London
- Dr Alice Sitch, University of Birmingham
- Professor Helen Minnis, University of Glasgow
- Professor Alan Stitt, Queen’s University Belfast
- Professor Carl Goodyear, University of Glasgow
- Professor Zion Tse, University of York
- Professor Rachel Williams, University of Liverpool
- Professor Jeremy Brown, University College London
See the Developmental Pathway Funding Scheme conflicts of interest register.
See the funding decision data for this scheme.
Last updated: 17 May 2022